Gary Neil Cramer offers Preventest from Syncier BioTech
Publish Date: 04-25-2017 21:56:38 | Contact name: Gary Cramer | 3160 times displayed | Comments |
PREVENTEST™ - The first Comprehensive Cancer Risk Assessment test designed to
determine your patient’s risk of developing up to eight types of cancer.
This non-invasive test helps physicians determine the level
of risk for some of the most common solid tumor cancers including
Breast, Ovarian, Endometrial,
Pancreas, Prostate, Skin, Stomach and Colorectal Cancers.
PREVENTEST™ can help identify the patient’s risk level of developing one
or more of these eight
prevalent cancers in early stage detection.
For more information please give Gary Cramer a call at 360-909-0723